Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. [electronic resource]
Producer: 20180507Description: 818-821 p. digitalISSN:- 1665-2681
- Adult
- Aged, 80 and over
- Chemical and Drug Induced Liver Injury -- diagnosis
- Cyclooxygenase 2 Inhibitors -- adverse effects
- Disease Progression
- Etodolac -- adverse effects
- Fatal Outcome
- Female
- Hepatic Encephalopathy -- chemically induced
- Humans
- Liver Failure, Acute -- chemically induced
- Liver Function Tests
- Risk Factors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.